Ischemia Reperfusion Injury Global Market Report 2025
상품코드:1730917
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
허혈재관류 손상 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연간 평균 성장률(CAGR) 7.7%로 성장할 전망이며, 22억 6,000만 달러로 성장이 예측됩니다. 향후 예측 기간 동안 성장은 바이오마커 기반 진단에 대한 수요 증가, 장기 보존 기술에 대한 의식 제고, 심근경색 이환율 상승, 의약품 연구개발에 대한 투자 증가, 줄기세포 치료에 대한 수요 증대 등의 요인에 의해 견인될 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 이미징 기술의 발전, 신규 약리학적 약제 개발, 치료에 있어 AI 및 머신러닝 통합, 장기 모델링을 위한 3D 프린팅 채택, 원격의료로의 전환 등을 들 수 있습니다.
심혈관 질환의 유병률 증가는 허혈재관류 손상 시장의 향후 성장을 가속할 것으로 예측됩니다. 심혈관 질환은 관상동맥 질환, 심부전, 뇌졸중 등 심장과 혈관에 영향을 미치는 질환군입니다. 이러한 질환의 증가는 주로 건강하지 못한 생활 습관과 인구의 고령화에 기인하고 있습니다. 포화지방, 설탕, 염분이 많은 식단과 운동 부족이 맞물려 심혈관 질환의 주요 위험인자인 비만, 고혈압, 당뇨병의 비율이 증가하고 있습니다. 허혈재관류 손상은 산화 스트레스, 염증, 세포사에 의한 조직 손상을 강화함으로써 심혈관계 질환을 악화시키고 최종적으로는 심기능을 해쳐 심부전이나 기타 합병증의 위험을 높입니다. 예를 들어 호주 보건복지연구소의 보고에 따르면 호주의 관상동맥성 심장질환으로 인한 사망자 수는 2021년 1만 4,100명에서 2022년 1만 4,900명으로 증가했습니다. 이처럼 심혈관질환 유병률 증가가 허혈재관류 손상 시장 성장에 기여하고 있습니다.
장기 이식의 빈도 증가는 허혈재관류 손상 시장의 성장을 더욱 밀어 올릴 것으로 예측됩니다. 장기 이식은 기능 부전 또는 손상된 장기를 대체하기 위해 건강한 장기를 기증자에서 레시피엔트로 외과적으로 이식하는 것을 포함합니다. 장기 이식의 증가는 의료 기술의 진보와 장기 부전 환자의 증가에 기인하고 있습니다. 수술기술, 면역억제제, 장기보존법의 개선으로 장기이식의 성공률은 현저히 향상되었습니다. 허혈재관류 손상(IRI)은 이식 중 고도의 보존 기술을 통해 관리할 수 있어 허혈에 의한 손상을 최소화하고 이식 장기의 기능과 생존율을 향상시킬 수 있습니다. 예를 들어 전미장기분할네트워크(UNOS)에 따르면 미국에서는 2022년 4만 2,887건의 장기이식이 이뤄졌고 2021년부터 3.7% 증가했습니다. 그 결과 장기이식의 증가가 허혈재관류 손상 시장 확대에 중요한 역할을 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 허혈재관류 손상 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 허혈재관류 손상 시장 : 성장률 분석
세계의 허혈재관류 손상 시장 실적 : 규모 및 성장(2019-2024년)
세계의 허혈재관류 손상 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 허혈재관류 손상 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 허혈재관류 손상 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
약물요법
비약물요법
세계의 허혈재관류 손상 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
심혈관 질환
뇌졸중
장기 이식
심장 발작
당뇨병
세계의 허혈재관류 손상 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
외래 서비스
노인 홈
세계의 허혈재관류 손상 시장 : 약물 요법 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
항산화 물질
항염증제
칼슘 채널 차단제
프리 라디칼 스캐빈저
일산화질소 공여체
미토콘드리아 보호제
세계의 허혈재관류 손상 시장 : 비약물 요법 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
허혈성 사전 컨디셔닝(IPC)
허혈성 포스트 컨디셔닝(IPO)
원격 허혈 컨디셔닝(RIC)
저체온 요법
기계적 개입
유전자 및 줄기세포 치료
제7장 지역별 및 국가별 분석
세계의 허혈재관류 손상 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 허혈재관류 손상 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
허혈재관류 손상 시장 : 경쟁 구도
허혈재관류 손상 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Prolong Pharmaceuticals LLC : 개요, 제품 및 서비스, 전략 및 재무 분석
BMG LABTECH GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Domainex Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
CFM Pharma Holding BV : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Simcere Innovation Inc.
Larix Bioscience LLC
Faron Pharmaceuticals Oy
LUCA Science Inc.
Faraday Pharmaceuticals Inc.
Athersys Inc.
Alloksys Life Sciences BV
Ischemix Inc.
New Horizons Pharma Inc.
Oxitope Pharma BV
PharmaTher Holdings Ltd
Revive Therapeutics Ltd
Corline Biomedical AB
Angion Biomedica Corp.
Radikal Therapeutics Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
허혈재관류 손상 시장(2029년) : 새로운 기회를 제공하는 국가
허혈재관류 손상 시장(2029년) : 새로운 기회를 제공하는 부문
허혈재관류 손상 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Ischemia-reperfusion injury refers to tissue damage that occurs when blood flow is restored to tissues after a period of ischemia (lack of oxygen). The return of circulation can lead to inflammation and oxidative damage. This injury involves complex pathophysiological processes that have both local and systemic effects.
The primary treatment types for ischemia-reperfusion injury include pharmacological and non-pharmacological therapies. Pharmacological treatments involve the use of medications designed to prevent or address the underlying mechanisms, such as oxidative stress, inflammation, and cell death. These therapies are applied in various conditions, including cardiovascular diseases, stroke, organ transplantation, heart attack, and diabetes. The end users of these treatments include hospitals, clinics, ambulatory services, and nursing homes.
The ischemia reperfusion injury market research report is one of a series of new reports from The Business Research Company that provides ischemia reperfusion injury market statistics, including the ischemia reperfusion injury industry global market size, regional shares, competitors with the ischemia reperfusion injury market share, detailed ischemia reperfusion injury market segments, market trends, and opportunities, and any further data you may need to thrive in the ischemia reperfusion injury industry. This ischemia reperfusion injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The ischemia reperfusion injury market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth observed during the historic period can be attributed to factors such as the increasing prevalence of cardiovascular diseases, a rise in surgical procedures, growing demand for organ transplantation, an expanding aging population, and a higher incidence of stroke.
The ischemia reperfusion injury market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. Looking ahead, the growth during the forecast period is expected to be driven by factors such as the increasing demand for biomarker-based diagnostics, greater awareness of organ preservation techniques, a rising incidence of myocardial infarction, higher investments in pharmaceutical research and development, and growing demand for stem cell therapies. Key trends anticipated in the forecast period include advancements in imaging technologies, the development of novel pharmacological agents, the integration of AI and machine learning in treatments, the adoption of 3D printing for organ modeling, and a shift toward telemedicine.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the ischemia-reperfusion injury market in the future. Cardiovascular diseases are a group of conditions that affect the heart and blood vessels, including coronary artery disease, heart failure, and stroke. The rise in these diseases is primarily attributed to unhealthy lifestyle habits and an aging population. Diets high in saturated fats, sugar, and salt, combined with insufficient physical activity, have contributed to rising rates of obesity, hypertension, and diabetes, which are major risk factors for cardiovascular conditions. Ischemia-reperfusion injury exacerbates cardiovascular diseases by intensifying tissue damage through oxidative stress, inflammation, and cell death, ultimately impairing heart function and raising the risk of heart failure and other complications. For example, the Australian Institute of Health and Welfare reported that deaths from coronary heart disease in Australia rose from 14,100 in 2021 to 14,900 in 2022. Thus, the increasing prevalence of cardiovascular diseases is contributing to the growth of the ischemia-reperfusion injury market.
The increasing frequency of organ transplants is expected to further boost the growth of the ischemia-reperfusion injury market. Organ transplantation involves the surgical transfer of a healthy organ from a donor to a recipient to replace a failing or damaged organ. The rise in organ transplants can be attributed to advances in medical technology and the growing number of organ failure patients. Improvements in surgical techniques, immunosuppressive drugs, and organ preservation methods have significantly enhanced the success rates of organ transplants. Ischemia-reperfusion injury (IRI) can be managed through advanced preservation techniques during transplantation, minimizing ischemia-induced damage and improving the function and survival of the transplanted organ. For instance, according to the United Network for Organ Sharing (UNOS), the United States saw 42,887 organ transplants in 2022, a 3.7% increase from 2021. As a result, the rise in organ transplants is playing a key role in the expansion of the ischemia-reperfusion injury market.
Companies in the ischemia-reperfusion injury market are focusing on developing innovative treatments, such as ketamine-based therapies, to prevent tissue damage and inflammation caused by ischemic events. Ketamine-based treatments use ketamine, a dissociative anesthetic, to address various health conditions, primarily in the treatment of mental health disorders such as depression, anxiety, and PTSD, as well as for pain management. For example, in December 2022, PharmaTher Holdings Ltd., a Canadian pharmaceutical company, received orphan drug designation from the U.S. Food and Drug Administration (FDA) for ketamine to prevent ischemia-reperfusion injury during organ transplantation. Ketamine reduces ischemia-reperfusion injury by inhibiting NF-κB, which suppresses the production of inflammatory cytokines such as IL-6 and TNF-a. Additionally, it exhibits anti-inflammatory properties by reducing leukocyte reactivity, helping minimize immune-mediated damage to transplanted organs.
Major players in the ischemia reperfusion injury market are Pfizer Inc., Prolong Pharmaceuticals LLC, BMG LABTECH GmbH, Domainex Ltd, CFM Pharma Holding BV, Simcere Innovation Inc., Larix Bioscience LLC, Faron Pharmaceuticals Oy, LUCA Science Inc., Faraday Pharmaceuticals Inc., Athersys Inc., Alloksys Life Sciences B.V., Ischemix Inc., New Horizons Pharma Inc., Oxitope Pharma BV, PharmaTher Holdings Ltd, Revive Therapeutics Ltd, Corline Biomedical AB, Angion Biomedica Corp., Radikal Therapeutics Inc.
North America was the largest region in the ischemia reperfusion injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ischemia-reperfusion injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ischemia-reperfusion injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ischemia-reperfusion injury market consists of revenues earned by entities by providing services such as diagnostic imaging services, surgical interventions, pharmacological treatment services, rehabilitation and physical therapy, research, and clinical trial services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ischemia-reperfusion injury market also includes sales of products including pharmaceuticals and therapeutics, medical devices, diagnostic tools and kits, reperfusion equipment, research tools, and reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ischemia Reperfusion Injury Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ischemia reperfusion injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ischemia reperfusion injury ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ischemia reperfusion injury market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Pharmacological Therapy; Non-pharmacological Therapy
2) By Application: Cardiovascular Diseases; Stroke; Organ Transplantation; Heart Attack; Diabetes
3) By End Users: Hospitals; Clinics; Ambulatory Services; Nursing Home
3. Ischemia Reperfusion Injury Market Trends And Strategies
4. Ischemia Reperfusion Injury Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Ischemia Reperfusion Injury Growth Analysis And Strategic Analysis Framework
5.1. Global Ischemia Reperfusion Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ischemia Reperfusion Injury Market Growth Rate Analysis
5.4. Global Ischemia Reperfusion Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ischemia Reperfusion Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ischemia Reperfusion Injury Total Addressable Market (TAM)
6.1. Global Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacological Therapy
Non-pharmacological Therapy
6.2. Global Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases
Stroke
Organ Transplantation
Heart Attack
Diabetes
6.3. Global Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Services
Nursing Home
6.4. Global Ischemia Reperfusion Injury Market, Sub-Segmentation Of Pharmacological Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antioxidants
Anti-inflammatory Agents
Calcium Channel Blockers
Free Radical Scavengers
Nitric Oxide Donors
Mitochondrial Protective Agents
6.5. Global Ischemia Reperfusion Injury Market, Sub-Segmentation Of Non-Pharmacological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ischemic Preconditioning (IPC)
Ischemic Postconditioning (IPO)
Remote Ischemic Conditioning (RIC)
Hypothermia Therapy
Mechanical Interventions
Gene and Stem Cell Therapy
7. Ischemia Reperfusion Injury Market Regional And Country Analysis
7.1. Global Ischemia Reperfusion Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ischemia Reperfusion Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ischemia Reperfusion Injury Market
9.1. China Ischemia Reperfusion Injury Market Overview
9.2. China Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ischemia Reperfusion Injury Market
10.1. India Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ischemia Reperfusion Injury Market
11.1. Japan Ischemia Reperfusion Injury Market Overview
11.2. Japan Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ischemia Reperfusion Injury Market
12.1. Australia Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ischemia Reperfusion Injury Market
13.1. Indonesia Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ischemia Reperfusion Injury Market
14.1. South Korea Ischemia Reperfusion Injury Market Overview
14.2. South Korea Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ischemia Reperfusion Injury Market
15.1. Western Europe Ischemia Reperfusion Injury Market Overview
15.2. Western Europe Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ischemia Reperfusion Injury Market
16.1. UK Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ischemia Reperfusion Injury Market
17.1. Germany Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ischemia Reperfusion Injury Market
18.1. France Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ischemia Reperfusion Injury Market
19.1. Italy Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ischemia Reperfusion Injury Market
20.1. Spain Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ischemia Reperfusion Injury Market
21.1. Eastern Europe Ischemia Reperfusion Injury Market Overview
21.2. Eastern Europe Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ischemia Reperfusion Injury Market
22.1. Russia Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ischemia Reperfusion Injury Market
23.1. North America Ischemia Reperfusion Injury Market Overview
23.2. North America Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ischemia Reperfusion Injury Market
24.1. USA Ischemia Reperfusion Injury Market Overview
24.2. USA Ischemia Reperfusion Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ischemia Reperfusion Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ischemia Reperfusion Injury Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
